I found news (Midnight Trader, which is my AMTD account) that during conference today they expected FY13 loss to be 70 to 74 mil
and net cash used in operations to be 78 to 82 mil and cash and marketable securites to be 172 mil to 176 mil.
Thats to me is a large part of why its down, plus someone here mention the 901 product is being delayed.
Plus VP Oleary sold 31,100 shrs
So yes there is a lot of news, and perhaps much of it was simply giving back yesterdays runup which was probably overblown expectations this conference would spark something positive
Agreed, but with new and interesting products in the pipeline & expansion of TDM-1 possible, I do not consider "potential" as overblown, but something in biotechs you have to monetize. It would seem over the long-run, this has much more upside.....just am interested for IMGN to demonstrate moves towards net zero.